AdaptHealth Corp. (AHCO) vs Sana Biotechnology, Inc. (SANA)
A side-by-side comparison of AdaptHealth Corp. and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.80HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
SANA
Sana Biotechnology, Inc.
$2.78HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — AHCO vs SANA
growth of $100 · dividends reinvested · last 6yAHCO -84.1% (-26.4%/yr)SANA -91.8% (-34.1%/yr)AHCO compounded faster over this window
AHCO SANA
AHCO vs SANA: by the numbers
- •AHCO is the larger company ($788M vs $772M market cap).
- •Both run net losses; SANA's is the smaller (0.00% vs -7.58% net margin).
Metrics side by side
Valuation
| Metric | AHCO | SANA |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 0.57 | 5.00 |
| EV / EBITDA | 6.64 | N/A |
| FCF yield | 12.39% | N/A |
Profitability
| Metric | AHCO | SANA |
|---|---|---|
| Gross margin | 10.37% | 0.00% |
| Operating margin | -0.31% | 0.00% |
| Net margin | -7.58% | 0.00% |
| ROE | -16.56% | -137.04% |
| ROIC | -0.26% | -67.58% |
Growth (annualized)
| Metric | AHCO | SANA |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | N/A |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -32.33% |
Frequently asked
- How have AHCO and SANA total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROESana Biotechnology ROEAdaptHealth operating marginSana Biotechnology operating marginAdaptHealth revenue growthSana Biotechnology revenue growthAdaptHealth free cash flowSana Biotechnology free cash flow
AdaptHealth & Sana Biotechnology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.